Xaira
PrivateLast Round
Series A
Apr 23, 2024
Est. Valuation
$2.7B
Total Funding Raised
$1B
Company Overview
Xaira Therapeutics is a biotechnology company focused on leveraging advanced artificial intelligence tools to enhance drug discovery and development through comprehensive product development and data generation.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Usage-Based SaaS
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xaira Comps
Public and private peers based on sector, stage, and business model.
Xaira Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 23, 2024 |
Key People
Founding team and executive leadership
Xaira Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Series A |
| SV Angel | Series A |
| New Enterprise Associates (NEA) | Series A |
| ARCH Venture Partners | Series A |
| F-Prime Capital | Series A |
| Risk and Return | Series A |
| Parker Institute for Cancer Immunotherapy | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
New model tests scaling laws in virtual cells.
- Jun 17, 2025
Launched X-Atlas/Orion, a large genome-wide Perturb-seq dataset.
Xaira Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xaira's valuation, stock price, and market status.
